Author:
Foissac Frantz,Blanche Stéphane,Dollfus Catherine,Hirt Déborah,Firtion Ghislaine,Laurent Corinne,Treluyer Jean-Marc,Urien Saïk
Subject
Pharmacology (medical),Pharmacology
Reference34 articles.
1. Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance;Wensing;Antiviral Res,2010
2. Food and Drug Administration (FDA) FDA Approves Atazanavir, a Once Daily Protease Inhibitor for HIV Infection 2003 http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm125077.htm
3. European Medicines Agency (EMEA) EPAR summuray for public, Reyataz, atazanavir 2010 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000494/WC500056381.pdf
4. Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the care study;Santoro;AIDS Patient Care STDS,2008
5. Efficacy and safety of boosted and unboosted atazanavir-containing antiretroviral regimens in real life: results from a multicentre cohort study;Giuntini;HIV Med,2010
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献